Appendix 2A — Application for Quotation of +Securities

Dec 1, 2021
Posted in: News, Investor updates

Home » Appendix 2A — Application for Quotation of +Securities

Appendix 2A — Application for Quotation of +Securities

Dec 1, 2021
Posted in: News, Investor updates

The following Appendix 2A was announced via ASX on 1 Dec 2021.

Please click to review full announcement.

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

November 13, 2025

We are excited to announce that Imagion Biosystems (ASX: IBX) will be attending two premier medical conferences this fall: the Radiological Society of North

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

November 5, 2025

FDA Submission of IND for MagSense® HER2 Phase 2 Clinical Trial on Track Q4 2025 Key Highlights: Wayne State University Collaboration Program Delivers Positive and

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

October 24, 2025

Video transcript: Advances in treatment for cancer have greatly improved survivability when the cancer is caught early. However, despite global spending of over $100

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appendix 2A — Application for Quotation of +Securities

Appendix 2A — Application for Quotation of +Securities

Related Articles

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list